Real-world studies confirm effectiveness of bulevirtide to treat chronic hepatitis D
In 2020,bulevirtide (BLV) was conditionally approved for treating chronic hepatitis delta (CHD), an inflammation of the liver caused by hepatitis D virus (HDV). Now real-world studies of patients treated outside of clinical trials confirm…